Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5Cell, 2022-10, Vol.185 (21), p.3992-4007.e16 [Peer Reviewed Journal]2022 The Author(s) ;Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;2022 The Author(s) 2022 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2022.09.018 ;PMID: 36198317Full text available |
|
2 |
Material Type: Article
|
Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variantCell host & microbe, 2022-11, Vol.30 (11), p.1540-1555.e15 [Peer Reviewed Journal]2022 The Author(s) ;Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;2022 The Author(s). Published by Elsevier Inc. 2022 ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2022.10.003 ;PMID: 36272413Full text available |
|
3 |
Material Type: Article
|
The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistanceCell reports (Cambridge), 2022-01, Vol.38 (2), p.110218-110218, Article 110218 [Peer Reviewed Journal]2021 The Author(s) ;Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved. ;2021 The Author(s) 2021 ;ISSN: 2211-1247 ;EISSN: 2211-1247 ;DOI: 10.1016/j.celrep.2021.110218 ;PMID: 34968415Full text available |
|
4 |
Material Type: Article
|
Virological characteristics of the SARS-CoV-2 Omicron BA.2 spikeCell, 2022-06, Vol.185 (12), p.2103-2115.e19 [Peer Reviewed Journal]2022 The Author(s) ;Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2022 The Author(s) 2022 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2022.04.035 ;PMID: 35568035Digital Resources/Online E-Resources |
|
5 |
Material Type: Article
|
Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variantThe Lancet infectious diseases, 2023-03, Vol.23 (3), p.280-281 [Peer Reviewed Journal]2023 Elsevier Ltd ;2023. Elsevier Ltd ;2023 Elsevier Ltd. All rights reserved. 2023 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(23)00051-8 ;PMID: 36736338Full text available |
|
6 |
Material Type: Article
|
Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivirPLoS pathogens, 2023-03, Vol.19 (3), p.e1011231-e1011231 [Peer Reviewed Journal]Copyright: © 2023 Torii et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ;COPYRIGHT 2023 Public Library of Science ;2023 Torii et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 Torii et al 2023 Torii et al ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/journal.ppat.1011231 ;PMID: 36972312Full text available |
|
7 |
Material Type: Article
|
Transmissibility, infectivity, and immune evasion of the SARS-CoV-2 BA.2.86 variantThe Lancet infectious diseases, 2023-11, Vol.23 (11), p.e460-e461 [Peer Reviewed Journal]2023 Elsevier Ltd ;2023. Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(23)00575-3Full text available |
|
8 |
Material Type: Article
|
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trialThe Lancet (British edition), 2022-04, Vol.399 (10335), p.1607-1617 [Peer Reviewed Journal]2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)02333-3 ;PMID: 35461558Full text available |
|
9 |
Material Type: Article
|
Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine SerumNew England Journal of Medicine, 2021-12, Vol.385 (25), p.2397-2399 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2114706 ;PMID: 34731554Digital Resources/Online E-Resources |
|
10 |
Material Type: Article
|
Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodiesThe Lancet infectious diseases, 2022-07, Vol.22 (7), p.942-943 [Peer Reviewed Journal]2022 Elsevier Ltd ;2022. Elsevier Ltd ;2022 Elsevier Ltd. All rights reserved. 2022 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(22)00365-6 ;PMID: 35690075Full text available |
|
11 |
Material Type: Article
|
The Natural Course of Unruptured Cerebral Aneurysms in a Japanese CohortThe New England journal of medicine, 2012-06, Vol.366 (26), p.2474-2482 [Peer Reviewed Journal]Copyright © 2012 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1113260 ;PMID: 22738097 ;CODEN: NEJMAGFull text available |
|
12 |
Material Type: Article
|
Leveraging fine-mapping and multipopulation training data to improve cross-population polygenic risk scoresNature genetics, 2022-04, Vol.54 (4), p.450-458 [Peer Reviewed Journal]2022. The Author(s), under exclusive licence to Springer Nature America, Inc. ;Copyright Nature Publishing Group Apr 2022 ;ISSN: 1061-4036 ;EISSN: 1546-1718 ;DOI: 10.1038/s41588-022-01036-9 ;PMID: 35393596Full text available |
|
13 |
Material Type: Article
|
Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 StudyJournal of clinical oncology, 2020-01, Vol.38 (2), p.115-123 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.01488 ;PMID: 31682542Full text available |
|
14 |
Material Type: Article
|
Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological studyBrain (London, England : 1878), 2020-05, Vol.143 (5), p.1431-1446 [Peer Reviewed Journal]The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0006-8950 ;EISSN: 1460-2156 ;DOI: 10.1093/brain/awaa102 ;PMID: 32412053Full text available |
|
15 |
Material Type: Article
|
Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritisNature genetics, 2022-11, Vol.54 (11), p.1640-1651 [Peer Reviewed Journal]2022. The Author(s), under exclusive licence to Springer Nature America, Inc. ;Copyright Nature Publishing Group Nov 2022 ;ISSN: 1061-4036 ;ISSN: 1546-1718 ;EISSN: 1546-1718 ;DOI: 10.1038/s41588-022-01213-w ;PMID: 36333501Full text available |
|
16 |
Material Type: Article
|
Virological characteristics of the SARS-CoV-2 JN.1 variantThe Lancet infectious diseases, 2024-02, Vol.24 (2), p.e82-e82 [Peer Reviewed Journal]2024. Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/s1473-3099(23)00813-7 ;PMID: 38184005Full text available |
|
17 |
Material Type: Article
|
Three-arm phase III trial comparing cisplatin plus 5-FU (CF) versus docetaxel, cisplatin plus 5-FU (DCF) versus radiotherapy with CF (CF-RT) as preoperative therapy for locally advanced esophageal cancer (JCOG1109, NExT study)Japanese journal of clinical oncology, 2013-07, Vol.43 (7), p.752-755 [Peer Reviewed Journal]ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyt061 ;PMID: 23625063Full text available |
|
18 |
Material Type: Article
|
Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitisJournal of gastroenterology, 2014-06, Vol.49 (6), p.961-970 [Peer Reviewed Journal]Springer Japan 2014 ;COPYRIGHT 2014 Springer ;ISSN: 0944-1174 ;EISSN: 1435-5922 ;DOI: 10.1007/s00535-014-0945-z ;PMID: 24639058Full text available |
|
19 |
Material Type: Article
|
East Asian-specific and cross-ancestry genome-wide meta-analyses provide mechanistic insights into peptic ulcer diseaseNature genetics, 2023-12, Vol.55 (12), p.2129-2138 [Peer Reviewed Journal]2023. The Author(s). ;Copyright Nature Publishing Group Dec 2023 ;ISSN: 1061-4036 ;EISSN: 1546-1718 ;DOI: 10.1038/s41588-023-01569-7 ;PMID: 38036781Full text available |
|
20 |
Material Type: Article
|
SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody EvasionThe Journal of infectious diseases, 2021-09, Vol.224 (6), p.989-994 [Peer Reviewed Journal]The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. 2021 ;The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiab368 ;PMID: 34260717Full text available |